Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses

Journal of Obstetrics and Gynaecology Canada

Volumn 31, Issue 7, 2009, Pages 668-673

  Le, Tien ^a   Giede, Christopher ^a   Salem, Shia ^a   Lefebvre, Guylaine ^a   Rosen, Barry ^a   Bentley, James ^a   Kupets, Rachel ^a   Power, Patti ^a   Renaud, Marie Claude ^a   Bryson, Peter ^a   Davis, Donald B ^b   Lau, Susie ^a   Lotocki, Robert ^a   Senikas, Vyta ^a   Morin, Lucie ^c   Bly, Stephen ^a   Butt, Kimberly ^a   Cargill, Yvonne M ^a   Denis, Nanette ^a   Gagnon, Robert ^a   Anne Hietala Coyle, Marja ^a   Lim, Kenneth Ian ^a   Ouellet, Annie ^a   Racicot, Maria Hélène ^a   more..

^a NONE   (Canada)

^b Def R and D Canada Suffield   (Canada)

^c NONE   (Canada)

Author keywords

Pelvic mass; Surgical management; Ultrasound evaluation

Indexed keywords

CA 125 ANTIGEN;

ABDOMINAL PAIN; ABDOMINAL SIZE; ADVANCED CANCER; ARTICLE; ASSESSMENT OF HUMANS; BLOATING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CYTOREDUCTIVE SURGERY; DIFFICULTY EATING; EARLY CANCER; EATING DISORDER; ECHOGRAPHY; EVIDENCE BASED MEDICINE; FEMALE; GENERAL PRACTITIONER; GYNECOLOGIST; HUMAN; LAPAROSCOPY; MEDICAL CARE; ONCOLOGIST; OVARY CANCER; OVERALL SURVIVAL; PATIENT REFERRAL; PELVIC PAIN; PELVIS CANCER; PHYSICAL PARAMETERS; POSTMENOPAUSE; PRACTICE GUIDELINE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK OF MALIGNANCY INDEX; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; SYSTEMATIC REVIEW (TOPIC); TRANSABDOMINAL ULTRASOUND; TRANSVAGINAL ECHOGRAPHY; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME; URINARY FREQUENCY; URINARY URGENCY;

EID: 70350474451     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34254-2     Document Type: Article

References (33)

1. Zhang J., Ugnat A.M., Clarke K., Mao Y. Ovarian cancer histology-specific incidence trends in Canada 1969-1993: age-period-cohort analyses. Br J Cancer 1999, 81(1):152-158.
2. Canadian Cancer Society Canadian cancer statistics Available at:, Accessed May 8, 2009. http://www.cancer.ca.
3. Chan J.K., Cheung M.K., Husain A., Teng N.N., West D., Whittemore A.S., et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol 2006, 108(3 Pt 1):521-528.
4. Tingulstad S., Skjeldestad F.E., Halvorsen T.B., Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003, 101(5 Pt 1):885-891.
5. Chan J.K., Loizzi V., Lin Y.G., Osann K., Brewster W.R., DiSaia P.J. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?. Obstet Gynecol 2003, 102(1):156-161.
6. Bristow R.E., Montz F.J., Lagasse L.D., Leuchter R.S., Karlan B.Y. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 1999, 72(3):278-287.
7. Jaaback K., Johnson N. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2006 Jan 25, 1:CD005340.
8. Earle C.C., Schrag D., Neville B.A., Yabroff K.R., Topor M., Fahey A., et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 2006, 98(3):172-180.
9. Engelen M.J., Kos H.E., Willemse P.H., Aalders J.G., de Vries E.G., Schaapveld M., et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006, 106(3):589-598.
10. Goff B.A., Mandel L.S., Drescher C.W., Urban N., Gough S., Schurman K.M., et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007, 109(2):221-227.
11. Milojkovic M., Hrgovic Z., Hrgovic I., Jonat W., Maass N., Bukovic D. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet 2004, 269(3):176-180.
12. Valentin L., Ameye L., Testa A., Lécuru F., Bernard J.P., Paladini D., et al. Ultrasound characteristics of different types of adnexal malignancies. Gynecol Oncol 2006, 102(1):41-48.
13. Brown D.L., Doubilet P.M., Miller F.H., Frates M.C., Laing F.C., DiSalvo D.N., et al. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 1998, 208(1):103-110.
14. Asif N., Sattar A., Dawood M.M., Rafi T., Aamir M., Anwar M. Pre-operative evaluation of ovarian mass: risk of malignancy index. J Coll Physicians Surg Pak 2004, 14(3):128-131.
15. Tingulstad S., Hagen B., Skjeldestad F.E., Onsrud M., Kiserud T., Halvorsen T., et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 1996, 103(8):826-831.
16. Morgante G., la Marca A., Ditto A., De Leo V. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynaecol 1999, 106(6):524-527.
17. Aslam N., Tailor A., Lawton F., Carr J., Savvas M., Jurkovic D. Prospective evaluation of three different models for the pre-operative diagnosis of ovarian cancer. BJOG 2000, 107(11):1347-1353.
18. Moore R.G., Brown A.K., Miller M.C., Skates S., Allard W.J., Verch T., et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 2008, 108(2):402-408.
19. Cohen L.S., Escobar P.F., Scharm C., Glimco B., Fishman D.A. Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecol Oncol 2001, 82(1):40-48.
20. Ioka A., Tsukuma H., Ajiki W., Oshima A. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci 2004 Mar, 95(3):233-237.
21. Paulsen T., Kjaerheim K., Kaern J., Tretli S., Trope C. Improved short term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer 2006, 16(Suppl 1):11-17.
22. Eisenkop S.M., Spirtos N.M., Montag T.W., Nalick R.H., Wang H.J. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 1992 Nov, 47(2):203-209.
23. Junor E.J., Hole D.J., McNulty L., Mason M., Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol 1999 Nov, 106(11):1130-1136.
24. Young R.C., Decker D.G., Wharton J.T., Piver M.S., Sindelar W.F., Edwards B.K., et al. Staging laparotomy in early ovarian cancer. JAMA 1983, 250:3072-3076.
25. Le T., Adolph A., Krepart G.V., Lotocki R., Heywood M.S. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 2002 May, 85(2):351-355.
26. Nguyen H.N., Averette H.E., Hoskins W., Penalver M., Sevin B.U., Steren A. National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival. Cancer 1993, 72(12):3663-3670.
27. Mayer A.R., Chambers S.K., Graves E., Home C., Tseng P.C., Nelson G.E., et al. Ovarian cancer staging: does it require a gynecologic oncologist?. Gynecol Oncol 1992, 47:223-227.
28. Elit L., Bondy S.J., Paszat L., Przybysz R., Levine M. Outcomes in surgery for ovarian cancer. Gynecol Oncol 2002, 87:260-267.
29. Trimbos J.B., Parmar M., Vergote I., Guthrie D., Bolis G., Colombo N., et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003, 95:105-112.
30. Trimbos J.B., Vergote I., Bolis G., Vermorken J.B., Mangioni C., Madronal C., et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003, 95(2):113-125.
31. Griffiths C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975, 42:101-104.
32. Giede K.C., Kieser K., Dodge J., Rosen B. Who should operate on patients with ovarian cancer? An evidence based review. Gynecol Oncol 2005, 99(2):447-461.
33. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169(3):207-208.